Replimune Group, Inc. (REPL) Insider Trading
Directors, officers and holders of more than 10% of REPL report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 79 transactions on file: 2 with code P, 18 with code S and 30 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Astley-Sparke Philip | Director | G Gift | 50,000 | Not measured | Not measured |
| Aug 17, 2026 | Hill Emily Luisa | Chief Financial Officer | S Sale | 9,256 | $14.28 | $132,176 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Director | P Purchase | 126,394 | $12.06 | $1,524,299 |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Director | P Purchase | 2,609,946 | $12.06 | $31,475,688 |
| Aug 10, 2026 | Schwendenman Andrew | Chief Accounting Officer | S Sale | 7,632 | $12.97 | $98,987 |
| Aug 10, 2026 | Xynos Konstantinos | Chief Medical Officer | S Sale | 11,447 | $12.97 | $148,468 |
| Aug 10, 2026 | Hill Emily Luisa | Chief Financial Officer | S Sale | 11,448 | $12.97 | $148,481 |
| Aug 10, 2026 | Patel Sushil | Chief Executive Officer | S Sale | 39,341 | $12.97 | $510,253 |
| Jun 1, 2026 | Sarchi Christopher | Chief Commercial Officer | S Sale | 12,000 | $9.24 | $110,880 |
| May 18, 2026 | Sarchi Christopher | Chief Commercial Officer | S Sale | 8,626 | $5.08 | $43,820 |
| May 18, 2026 | Hill Emily Luisa | Chief Financial Officer | S Sale | 7,812 | $5.08 | $39,685 |
| May 18, 2026 | Astley-Sparke Philip | Director | S Sale | 17,657 | $5.08 | $89,698 |
| May 18, 2026 | Patel Sushil | Chief Executive Officer | S Sale | 37,324 | $5.08 | $189,606 |
| May 18, 2026 | Xynos Konstantinos | Chief Medical Officer | S Sale | 14,023 | $5.08 | $71,237 |
| May 18, 2026 | Schwendenman Andrew | Chief Accounting Officer | S Sale | 7,894 | $5.08 | $40,102 |
| Apr 2, 2026 | Sarchi Christopher | Chief Commercial Officer | S Sale | 6,500 | $8.01 | $52,065 |
| Apr 1, 2026 | Balachandran Madhavan | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Oliger Christy J. | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Astley-Sparke Philip | Director | A Award | 75,000 | Not measured | Not measured |
| Apr 1, 2026 | Sarchi Christopher | Chief Commercial Officer | A Award | 75,000 | Not measured | Not measured |
| Apr 1, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Weinand Dieter | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Hill Emily Luisa | Chief Financial Officer | A Award | 75,000 | Not measured | Not measured |
| Apr 1, 2026 | Peeples-Dyer Veleka | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Sarchi Christopher | Chief Commercial Officer | A Award | 50,000 | Not measured | Not measured |
| Apr 1, 2026 | Astley-Sparke Philip | Director | A Award | 50,000 | Not measured | Not measured |
| Apr 1, 2026 | Xynos Konstantinos | Chief Medical Officer | A Award | 50,000 | Not measured | Not measured |
| Apr 1, 2026 | Schwendenman Andrew | Chief Accounting Officer | A Award | 36,667 | Not measured | Not measured |
| Apr 1, 2026 | Patel Sushil | Chief Executive Officer | A Award | 251,240 | Not measured | Not measured |
| Apr 1, 2026 | Hill Emily Luisa | Chief Financial Officer | A Award | 50,000 | Not measured | Not measured |
| Apr 1, 2026 | SLATTERY JOSEPH P | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Pucci Paolo | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Dhingra Kapil | Director | A Award | 44,500 | Not measured | Not measured |
| Apr 1, 2026 | Patel Sushil | Chief Executive Officer | A Award | 376,860 | Not measured | Not measured |
| Apr 1, 2026 | Schwendenman Andrew | Chief Accounting Officer | A Award | 55,000 | Not measured | Not measured |
| Apr 1, 2026 | Xynos Konstantinos | Chief Medical Officer | A Award | 75,000 | Not measured | Not measured |
| Feb 18, 2026 | Astley-Sparke Philip | Director | G Gift | 25,000 | Not measured | Not measured |
| Dec 19, 2025 | Patel Sushil | Chief Executive Officer | A Award | 200,000 | Not measured | Not measured |
| Dec 19, 2025 | Schwendenman Andrew | Chief Accounting Officer | A Award | 10,000 | Not measured | Not measured |
| Dec 19, 2025 | Sarchi Christopher | Chief Commercial Officer | A Award | 35,000 | Not measured | Not measured |
| Dec 19, 2025 | Hill Emily Luisa | Chief Financial Officer | A Award | 60,000 | Not measured | Not measured |
| Dec 19, 2025 | Xynos Konstantinos | Chief Medical Officer | A Award | 60,000 | Not measured | Not measured |
| Dec 9, 2025 | Dhingra Kapil | Director | M Exercise | 3,169 | Not measured | Not measured |
| Dec 9, 2025 | Dhingra Kapil | Director | S Sale | 3,169 | $10.40 | $32,958 |
| Dec 9, 2025 | Dhingra Kapil | Director | M Exercise | 3,169 | $1.75 | $5,546 |
| Dec 2, 2025 | Patel Sushil | Chief Executive Officer | S Sale | 10,000 | $11.13 | $111,300 |
| Nov 17, 2025 | Xynos Konstantinos | Chief Medical Officer | S Sale | 7,248 | $9.10 | $65,957 |
| Nov 17, 2025 | Sarchi Christopher | Chief Commercial Officer | S Sale | 5,208 | $9.10 | $47,393 |
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | S Sale | 9,154 | $5.37 | $49,157 |
The full Form 4 history is on the REPL company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.